Which company makes Erlotinib?

Erlotinib(Erlotinib) was first developed by the American biopharmaceutical company OSI Pharmaceuticals, and was later promoted in cooperation with Roche and Genentech. In 2004, the U.S. FDA approved erlotinib for the treatment of non-small cell lung cancer (NSCLC). Since then, its indications have been expanded in areas such as pancreatic cancer. With the global launch of Tarceva, Roche Group has become the main manufacturer and marketer of this drug.

Roche is a multinational pharmaceutical company headquartered in Switzerland with deep R&D and market presence in the field of oncology. As one of Roche's important products in the era of molecular targeted therapy, Tarceva, together with bevacizumab, trastuzumab and other drugs, forms the core lineup of its anti-cancer drug pipeline. Genentech, as a subsidiary of Roche, has played a key role in the US market, making Tarceva quickly become one of the clinical standard drugs for EGFR-TKI.

It is worth noting that as the patent gradually expires, generic versions of erlotinib have been approved for marketing in many countries. This has significantly increased the availability of the drug and is driving changes in the treatment landscape for lung cancer patients worldwide. In some developing countries, the popularity of generic drugs has greatly reduced the cost of treatment, allowing more patients to afford long-term targeted therapy.

At present, Roche is still the original drug holder of erlotinib, which has advantages in production technology, drug quality and global supply chain management. The generic versions of pharmaceutical companies in various places have gradually met the broad needs of the market while ensuring bioequivalence. It can be said that erlotinib went from an innovative molecule of a biotechnology company to a core product owned by a global pharmaceutical giant, and finally entered the stage of universally accessible generic drugs, completely demonstrating the entire process of modern anti-cancer drug R&D and marketization.

Reference materials:https://en.wikipedia.org/wiki/Erlotinib